Thiotepa-based conditioning regimens in allogeneic hematopoietic stem cell transplantation for patients with myelofibrosis

被引：0
|
作者：
Dulery, R.
Giannotti, F. [1 ]
Battipaglia, G. [1 ]
Ruggeri, A. [1 ]
Brissot, E. [1 ,2 ,3 ]
Malard, F. [1 ]
Sestili, S. [1 ]
Belhocine, R. [1 ]
Vekhoff, A. [1 ]
Gueye, M. S. [1 ]
Lapusan, S. [1 ]
Adaeva, R. [1 ]
Isnard, F. [1 ]
Legrand, O. [1 ,3 ]
Mohty, M. [1 ,2 ,3 ]
机构：
[1] St Antoine Hosp, AP HP, Dept Hematol & Cellular Therapy, Paris, France
[2] INSERM, UMRs 938, Paris, France
[3] Univ Paris 06, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P422
引用
收藏
页码：S337 / S337
页数：1
相关论文
共 50 条
  • [1] Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
    Krzysztof Kalwak
    Monika Mielcarek
    Katharine Patrick
    Jan Styczynski
    Peter Bader
    Selim Corbacioglu
    Birgit Burkhardt
    Karl Walter Sykora
    Katarzyna Drabko
    Jolanta Gozdzik
    Franca Fagioli
    Johann Greil
    Bernd Gruhn
    Rita Beier
    Franco Locatelli
    Ingo Müller
    Paul Gerhardt Schlegel
    Petr Sedlacek
    Klaus Daniel Stachel
    Claudia Hemmelmann
    Ann-Kristin Möller
    Joachim Baumgart
    Ajay Vora
    Bone Marrow Transplantation, 2020, 55 : 1996 - 2007
  • [2] Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis
    Shouval, Roni
    Vega, Yakov
    Fein, Joshua A.
    Danylesko, Ivetta
    Tov, Noga Shem
    Yerushalmi, Ronit
    Sobas, Marta
    Czyz, Anna
    Nagler, Arnon
    Shimoni, Avichai
    BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 147 - 156
  • [3] Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis
    Roni Shouval
    Yakov Vega
    Joshua A. Fein
    Ivetta Danylesko
    Noga Shem Tov
    Ronit Yerushalmi
    Marta Sobas
    Anna Czyż
    Arnon Nagler
    Avichai Shimoni
    Bone Marrow Transplantation, 2020, 55 : 147 - 156
  • [4] THIOTEPA-TREOSULFAN-FLUDARABINE (TTF) AS CONDITIONING REGIMEN IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLOHSCT) FOR MYELOFIBROSIS
    Canale, Filippo Antonio
    Porto, Gaetana
    Verduci, Chiara
    Celentano, Maria
    Loteta, Barbara
    Pugliese, Marta
    Naso, Virginia
    Moscato, Tiziana
    Irrera, Giuseppe
    Console, Giuseppe
    Ferreri, Anna
    Picardi, Alessandra
    Martino, Massimo
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 496 - 497
  • [5] Allogeneic stem cell transplantation with a thiotepa-based conditioning regimen for poor prognosis haematological patients: a single-centre experience
    Pelosini, M.
    Sordi, E.
    Benedetti, E.
    Caracciolo, F.
    Papineschi, F.
    Petrini, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S405 - S406
  • [6] Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations
    Henes, Joerg C.
    Koetter, Ina
    Horger, Marius
    Schmalzing, Marc
    Mueller, Karin
    Eick, Christian
    Bauer, Axel
    Vogel, Wichard
    Kanz, Lothar
    RHEUMATOLOGY, 2014, 53 (05) : 919 - 922
  • [7] Thiotepa-Based Conditioning Regimen Compared to Non-Thiotepa Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in β Thalassemia Major: Impact on Survival
    Tan, Wanxia
    He, Yuelin
    Feng, Xiaoqin
    Wu, Xuedong
    Li, Chunfu
    Liao Jianyun
    Peng, Zhiyong
    Ruan, Yongsheng
    Hui, Ge
    Liu, Xiaoting
    Ren, Yuqiong
    BLOOD, 2018, 132
  • [8] Thiotepa-busulfan-fludarbine as Conditioning Regimen for Patients with Myelofibrosis undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
    Memoli, Mara
    Paviglianiti, Annalisa
    Malard, Florent
    Battipaglia, Giorgia
    Brissot, Eolia
    Mediavilla, Clemence
    Bianchessi, Antonio
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Lapusan, Simona
    Bonnin, Agnes
    Vekhoff, Anne
    Legrand, Ollivier
    Mohty, Mohamad
    Dulery, Remy
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 307 - 308
  • [9] Fludarabine, busulfan, and thiotepa may be a promising conditioning regimen for myelofibrosis patients undergoing allogeneic stem cell transplantation
    Shouval, Roni
    Vega, Yakov
    Fein, Joshua A.
    Danylesko, Ivetta
    Tov, Noga Shem
    Yerushalmi, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    BONE MARROW TRANSPLANTATION, 2019, 54 : 204 - 205
  • [10] Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    Fujimaki, K
    Taguchi, J
    Fujita, H
    Hattori, M
    Yamazaki, E
    Takahashi, N
    Fujisawa, S
    Kanamori, H
    Maruta, A
    Ishigatsubo, Y
    BONE MARROW TRANSPLANTATION, 2004, 33 (08) : 789 - 792
12345